Patient Education Sheet Library
Search Results
Zoledronic Acid
Zoledronic acid is used to treat soft, brittle bones (osteoporosis), for bone growth, to treat…
Treatment Given by InfusionDownloads
Download (English) – 0.34MBPamidronate
Pamidronate is used for bone growth, to treat bone loss in patients getting certain treatments…
Treatment Given by InfusionDownloads
Trastuzumab, Capecitabine, and Cisplatin
The combination of trastuzumab, capecitabine, and cisplatin is used for stomach cancer, esophagus cancer, and…
Treatment Given by Infusion Treatment Taken by MouthDownloads
Pembrolizumab, Trastuzumab, Capecitabine, and Cisplatin
The combination of pembrolizumab, trastuzumab, capecitabine, and cisplatin is used for stomach cancer, esophagus cancer,…
Treatment Given by Infusion Treatment Taken by MouthDownloads
Pembrolizumab, Trastuzumab, and CAPOX
The combination of pembrolizumab, trastuzumab, and CAPOX (capecitabine and oxaliplatin) is used for stomach cancer,…
Treatment Given by Infusion Treatment Taken by MouthDownloads
Retifanlimab, Carboplatin, and Paclitaxel
The combination of retifanlimab, carboplatin, and paclitaxel is used for anal cancer.
Treatment Given by InfusionDownloads
Trastuzumab, Fluorouracil, Leucovorin, and Cisplatin
The combination of trastuzumab, fluorouracil (5-FU), leucovorin, and cisplatin is used for stomach cancer, esophageal…
Treatment Given by InfusionDownloads
Elotuzumab and Pd
The combination of elotuzumab, pomalidomide, and dexamethasone (Elo-Pd) are used for multiple myeloma.
Treatment Given by Infusion Treatment Taken by MouthDownloads
Downloads
Isatuximab and VRd
The combination of isatuximab, bortezomib, lenalidomide, and dexamethasone (Isa-VRd) is used for multiple myeloma.
Treatment Given by Infusion Treatment Given by Injection Treatment Taken by MouthDownloads
Popular Searches
PES Review Committee
The Patient Education Sheet (PES) Committee is a multidisciplinary team of oncology professionals who guide the development and review of these important resources. This committee ensures that every PES is accurate, clear, and meaningful for patients and caregivers navigating cancer treatment.
Led by NCODA and supported through collaboration with three leading professional organizations—ACCC, HOPA, and ONS—the committee combines expertise from across the oncology care spectrum. Together, they uphold best practices, promote consistency in patient education, and remain committed to improving outcomes through accessible, patient-centered information.
